Healthcare -
Biotechnology - NASDAQ - US
$ 7.54
-5.16 %
$ 63.5 M
Market Cap
-0.54
P/E
KPTI - OPERATING INCOME
Operating Income KPTI - Karyopharm Therapeutics Inc.
-119 M
LAST VALUE
8.35%
2 YEAR CAGR
8.80%
5 YEAR CAGR
-4.65%
10 YEAR CAGR